Zhejiang Huahai Pharmaceutical Co., Ltd. Class ASSE: 600521

Announcement on Disclosure of the 2025 Annual Report by the Holding Subsidiary, Changxing Pharmaceutical Co., Ltd.

· Issued by Zhejiang Huahai Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Disclosure of the 2025 Annual Report by the Holding Subsidiary, Changxing Pharmaceutical Co., Ltd.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment